Processa Pharmaceuticals, Inc.: 10-Q filed 2014-08-19
What Processa Pharmaceuticals, Inc. reported in its quarterly report filed 2014-08-19 (fiscal Q2 2014): 36 published measures, 96 facts as tagged in accession 0001393905-14-000488.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2014-08-19
- Fiscal period
- fiscal Q2 2014
- Accession
- 0001393905-14-000488 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Processa Pharmaceuticals, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 2,784,698 | USD | |
| At 2013-12-31 | 2,938,053 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 2,161,710 | USD | |
| At 2013-12-31 | 1,267,175 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 622,988 | USD | |
| At 2013-12-31 | 1,670,878 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 39,899 | USD | |
| At 2013-12-31 | 186,864 | USD | |
| At 2013-06-30 | 629,804 | USD | |
| At 2012-12-31 | 1,027,475 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -851,216 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -2,195,495 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -726,571 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -1,542,936 | USD | 181 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | -1,695,826 | USD | 181 |
| 2013-01-01 to 2013-06-30 | -1,366,907 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 15,772 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 7,332 | USD | 181 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 112,835 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 133,180 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 97,280 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 116,480 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 1,561,278 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 976,568 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | -12,417 | USD | 181 |
| 2013-01-01 to 2013-06-30 | -7,332 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | -9,130,633 | USD | |
| At 2013-12-31 | -6,813,758 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -25 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -50 | USD | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 443,668 | USD | |
| At 2013-12-31 | 369,775 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 163,721 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 49,693 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 466,028 | USD | |
| At 2013-12-31 | 514,706 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -112,935 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -173,032 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -33,754 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -49,643 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 561,726 | USD | |
| At 2013-12-31 | 1,121,717 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 111,962 | USD | |
| At 2013-12-31 | 77,028 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 780,901 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 2,076,335 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 728,965 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 1,537,157 | USD | 181 |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 206,277 | USD | |
| At 2013-12-31 | 228,256 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 42,643 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 53,848 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 35,755 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 42,830 | USD | 181 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 712,406 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 1,517,412 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 665,605 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 1,402,171 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 68,495 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 168,264 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 63,360 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 134,986 | USD | 181 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 8,283,730 | shares | |
| At 2013-12-31 | 8,082,000 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 9,752,689 | USD | |
| At 2013-12-31 | 8,483,727 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 570,433 | USD | |
| At 2013-12-31 | 446,898 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | -126,765 | USD | |
| At 2013-12-31 | -77,123 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 155,474 | USD | |
| At 2013-12-31 | 258,006 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2014-06-30 | 120,822 | USD | |
| At 2013-12-31 | 80,386 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -851,191 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -2,195,445 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -726,571 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -1,542,936 | USD | 181 |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -851,216 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -2,195,495 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -726,571 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -1,542,936 | USD | 181 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | -912,351 | USD | 91 |
| 2014-01-01 to 2014-06-30 | -2,254,649 | USD | 181 |
| 2013-04-01 to 2013-06-30 | -768,358 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -1,626,048 | USD | 181 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-04-01 to 2014-06-30 | 23,358 | USD | 91 |
| 2014-01-01 to 2014-06-30 | 45,133 | USD | 181 |
| 2013-04-01 to 2013-06-30 | 13,223 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 26,256 | USD | 181 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 178,570 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 178,571 | USD | 181 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | -61,733 | USD | 181 |
| 2013-01-01 to 2013-06-30 | -149,623 | USD | 181 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2014-01-01 to 2014-06-30 | 6,194 | USD | 181 |
| 2013-01-01 to 2013-06-30 | 160,109 | USD | 181 |
Inspect the source
- Entity
- Processa Pharmaceuticals, Inc. / CIK 0001533743
- Captured
- 2026-09-20T09:16:31.348Z
- SEC response SHA-256
5f3216d9024f2a7fc94b315f5bf243c7efb048273a6be394a2f74186d7af2a31
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001533743.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))